Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Milton › NPI 1174618953
Hospital

Beth Israel Deaconess Hospital Milton INC

Beth Israel Deaconess Hospital Milton INC was paid $21.83M by Medicaid between Jan 2018 and Dec 2024, across 247 billing codes. Its largest line is 99285, emergency room visit (most serious) — 17% of everything it billed.

33Billing provider infoBETH ISRAEL DEACONESS HOSPITAL MILTON INC
MILTON, MA 02186
33aNPI1174618953assigned 10/04/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$21.83M
24GClaims701,173
24DCodes billed247
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Massachusetts

Rank by total paid#39 of 66
Median peer was paid$29.11M
This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201884,347$2.39M
201982,282$2.17M
202077,803$2.12M
2021113,682$3.35M
2022109,084$3.64M
2023124,647$4.39M
2024incomplete109,328$3.77M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 17% 23,151 21,215 $3.63M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 12% 17,890 16,986 $2.64M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.4% 14,405 13,535 $2.05M
96361 Intravenous infusion, hydration; each additional hour 8.2% 5,292 4,851 $1.79M
45380 Colonoscopy, flexible; with biopsy, single or multiple 3.3% 658 652 $722K
G0378 Hospital observation service, per hour 3.2% 6,387 3,683 $702K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.8% 4,988 4,729 $612K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2.6% 3,244 3,086 $559K
70450 Computed tomography, head or brain; without contrast material 2.2% 5,417 5,121 $478K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.1% 3,030 2,929 $458K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2.0% 2,160 2,107 $427K
77063 Screening digital breast tomosynthesis, bilateral 1.7% 4,928 4,878 $369K
235 more codes
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.6% 6,786 $352K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.6% 4,754 $344K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 1.5% 361 $338K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.5% 6,822 $338K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.4% 385 $306K
S9485 Crisis intervention mental health services, per diem 1.4% 694 $300K
71046 Radiologic examination, chest; 2 views 1.3% 12,027 $288K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,220 $218K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,352 $217K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 1,560 $217K
80053 Comprehensive metabolic panel <1% 42,766 $215K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 6,720 $189K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 40,448 $172K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 914 $148K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 9,113 $139K
77067 Screening mammography, bilateral, including computer-aided detection <1% 4,990 $121K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,718 $109K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 3,849 $102K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 3,314 $88K
84484 <1% 11,541 $85K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 10,090 $84K
83036 Hemoglobin; glycosylated (A1C) <1% 16,418 $84K
76830 Ultrasound, transvaginal <1% 862 $84K
84443 Thyroid stimulating hormone (TSH) <1% 12,652 $83K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 766 $82K
80061 Lipid panel <1% 21,605 $78K
80050 General health panel <1% 4,535 $74K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,771 $71K
80048 Basic metabolic panel (calcium, ionized) <1% 18,623 $70K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 4,185 $67K
71275 Computed tomographic angiography, chest, with contrast material <1% 377 $67K
73630 <1% 2,196 $65K
93971 <1% 656 $61K
62323 <1% 156 $60K
73030 <1% 1,973 $56K
83735 <1% 13,208 $51K
85027 <1% 15,152 $49K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 275 $48K
73564 <1% 1,616 $48K
82607 <1% 5,587 $44K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 406 $43K
ATP14 <1% 6,502 $43K
83690 <1% 9,126 $40K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 931 $40K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 903 $39K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,516 $38K
87086 Culture, bacterial; quantitative colony count, urine <1% 8,730 $37K
87631 <1% 416 $36K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 17,845 $36K
77080 <1% 459 $36K
73610 <1% 1,306 $35K
83970 <1% 2,174 $35K
82728 <1% 4,565 $34K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 93 $33K
71045 Radiologic examination, chest; single view <1% 6,922 $32K
72100 <1% 1,086 $32K
73562 <1% 1,272 $31K
86803 <1% 1,872 $30K
58558 <1% 14 $29K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,286 $28K
0002A <1% 847 $26K
73130 <1% 1,056 $26K
81025 <1% 5,971 $26K
84466 <1% 3,929 $25K
73560 <1% 730 $25K
85610 <1% 6,185 $24K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,777 $23K
84702 <1% 2,125 $23K
82948 <1% 5,075 $22K
84153 <1% 1,464 $22K
82746 <1% 1,929 $21K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,479 $20K
0011A <1% 983 $20K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 266 $19K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 12 $19K
86850 <1% 2,777 $18K
0001A <1% 802 $18K
81001 <1% 10,118 $18K
83880 <1% 1,313 $18K
83540 <1% 5,179 $18K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 412 $17K
76536 <1% 160 $16K
84439 <1% 3,352 $16K
0012A <1% 563 $16K
82570 <1% 6,800 $15K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,155 $15K
87430 <1% 1,287 $15K
86901 <1% 2,958 $14K
73502 <1% 609 $14K
ATP15 <1% 1,774 $14K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 126 $14K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 595 $14K
80074 <1% 439 $14K
81003 <1% 10,334 $14K
83605 <1% 2,338 $14K
96375 Therapeutic injection; each additional sequential IV push <1% 6,836 $13K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,576 $13K
82043 <1% 5,677 $13K
87186 <1% 2,805 $13K
84100 <1% 9,235 $12K
ATP08 <1% 2,783 $12K
36415 Collection of venous blood by venipuncture <1% 29,725 $12K
J2704 Injection, propofol, 10 mg <1% 6,281 $11K
84703 <1% 1,943 $11K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 257 $10K
86140 <1% 3,105 $10K
80143 <1% 1,732 $10K
87070 <1% 1,498 $10K
73110 <1% 353 $9K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 12 $9K
97162 <1% 168 $9K
87480 <1% 520 $9K
87510 <1% 520 $9K
87660 <1% 521 $9K
86480 <1% 194 $8K
86900 <1% 2,662 $8K
86592 <1% 1,330 $8K
99215 Doctor's office visit, returning patient (complex) <1% 39 $8K
71250 <1% 153 $7K
80076 <1% 3,916 $7K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 156 $7K
87400 <1% 393 $7K
85730 <1% 2,055 $6K
85379 <1% 863 $6K
76642 <1% 54 $6K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,963 $5K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 99 $5K
72125 Computed tomography, cervical spine; without contrast material <1% 999 $5K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 7,017 $4K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,848 $4K
85007 <1% 2,109 $4K
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg <1% 684 $4K
87040 <1% 453 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,070 $4K
85652 <1% 2,451 $4K
82550 <1% 3,013 $4K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 826 $3K
82565 <1% 1,183 $3K
97803 <1% 42 $3K
87340 <1% 327 $3K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,683 $3K
80305 <1% 556 $3K
76000 <1% 93 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 297 $3K
J9035 Injection, bevacizumab, 10 mg <1% 12 $3K
84550 <1% 3,065 $3K
86706 <1% 247 $3K
87081 <1% 538 $3K
93017 <1% 26 $2K
86765 <1% 59 $2K
86618 <1% 154 $2K
72170 <1% 222 $2K
20553 <1% 12 $2K
70496 <1% 13 $2K
J0690 Injection, cefazolin sodium, 500 mg <1% 556 $2K
88142 <1% 85 $2K
ATP17 <1% 2,822 $2K
73140 <1% 39 $2K
84300 <1% 913 $2K
84156 <1% 1,046 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 411 $1K
86038 <1% 149 $1K
86708 <1% 119 $1K
J1644 Injection, heparin sodium, per 1000 units <1% 612 $1K
86703 <1% 126 $1K
84460 <1% 746 $1K
84133 <1% 805 $1K
87077 <1% 311 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 111 $1K
82436 <1% 661 $1K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 241 $1K
85651 <1% 460 $1K
84450 <1% 485 $1K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 44 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 428 $982.21
J2060 Injection, lorazepam, 2 mg <1% 555 $978.89
71271 <1% 14 $943.37
88312 <1% 126 $925.46
84480 <1% 91 $778.83
86762 <1% 14 $769.67
ATP21 <1% 307 $755.68
91301 <1% 682 $729.55
J1040 Injection, methylprednisolone acetate, 80 mg <1% 198 $621.87
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 274 $603.36
84481 <1% 45 $596.27
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 13 $543.61
84403 <1% 27 $527.23
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 284 $497.18
84145 <1% 63 $475.43
99218 <1% 43 $448.43
82947 <1% 127 $399.49
84520 <1% 307 $382.06
86735 <1% 14 $371.53
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 427 $351.25
ATP11 <1% 259 $331.08
J7030 Infusion, normal saline solution , 1000 cc <1% 16 $305.44
82803 <1% 26 $288.90
88304 <1% 38 $268.19
ATP03 <1% 157 $207.60
80051 <1% 44 $202.15
82248 <1% 129 $190.30
87088 <1% 28 $145.48
86431 <1% 25 $141.10
Q3014 Telehealth originating site facility fee <1% 75 $137.46
83935 <1% 25 $120.03
90715 <1% 17 $107.36
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 78 $92.90
87205 <1% 12 $69.47
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 241 $65.95
96376 <1% 152 $55.22
82962 <1% 283 $51.02
90686 <1% 15 $33.48
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 229 $33.42
94762 <1% 60 $32.25
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 15 $27.78
84075 <1% 25 $26.81
82040 <1% 13 $26.19
77003 <1% 12 $24.63
81005 <1% 12 $24.10
81015 <1% 366 $21.98
84155 <1% 12 $13.48
ATP18 <1% 112 $10.97
83721 <1% 14 $8.70
J1790 Injection, droperidol, up to 5 mg <1% 51 $7.74
82310 <1% 61 $2.41
83550 0% 109 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 118 $0.00
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 0% 14 $0.00
80320 0% 62 $0.00
84132 0% 14 $0.00
80329 0% 41 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 15 $0.00
83615 0% 16 $0.00
91300 0% 1,034 $0.00
94664 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRANGAVIZ, SHEILAH (CHIEF FINANCIAL OFFICER)
Same official

Other billing entities under RANGAVIZ, SHEILAH

Full network →
ProviderLocationPaid
Bid-Milton Physician Associates INCQuincy, MA$41K
Community Physicians Associates, INC.Milton, MA$14K
Community Physicians Associates, INC.Milton, MA$287.88

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.